Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
CA 2933552
ASSOCIATIONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX ACARIENS
granted -
US 9068165
Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer
granted -
US 9068003
Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
granted -
US 9066936
Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent
granted -
US 9066957
Dry powder inhaler
granted -
US 9066982
Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
granted -
US 9067932
Pyrazolopyridine kinase inhibitors
granted -
US 9067989
Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
granted -
US 9067968
Tight junction protein modulators and uses thereof
granted -
US 9068185
Antisense modulation of nuclear hormone receptors
granted -
US 9068007
Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
granted -
US 9068014
Colon and pancreas cancer peptidomimetics
granted -
US 9068002
Treatment of multiple sclerosis and/or rheumatoid arthritis
granted -
US 9067961
Thiocarbon-protecting groups for RNA synthesis
granted -
US 9067962
Methods of treating diabetes
granted -
US 9067891
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors
granted -
US 9066965
Purified limonin glucoside for prevention and treatment of chronic diseases
granted -
US 9067925
Compositions and methods for inhibition of the JAK pathway
granted -
US 9066967
Oligonucleotide analogues targeting human LMNA
granted -
US 9066944
Hepatitis C virus inhibitors
granted -
US 9066943
Use of botulinum toxin therapy for treatment of urological neurological conditions
granted -
US 9066948
Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines
granted -
US 9066907
Methods for treating burns-related systemic inflammatory response syndrome
granted -
US 9066904
Composition containing an essential oil product and method for using such to maintain normal levels of testosterone
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.